The role of CD4 in T-cell activation: accessory molecule or co-receptor?
about
p70 phosphorylation and binding to p56lck is an early event in interleukin-2-induced onset of cell cycle progression in T-lymphocytesHuman immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNADifferential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epitheliaCD4-T-cell antigen receptor complexes on human leukemia T cells.Cross-linking of CD4 in a TCR/CD3-juxtaposed inhibitory state: a pFRET studyRelative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxinRepression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events.Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells.Current imaging strategies in rheumatoid arthritisHuman CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function.Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene.CD4/immunoglobulin interaction: implications for immune physiology and autoimmunity.Cell-surface molecules in the regulation of immune responsiveness.The c-src family of protein-tyrosine kinases.High thioredoxin-1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody TregalizumabMutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly.Improving potencies and properties of CD4 down-modulating CADA analogs.Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4.Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.The distribution of immune cells in the uveal tract of the normal eye.The allogeneic CD4+ T-cell-mediated graft-versus-leukemia effect.Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules.Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4.Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation.Fasciola hepatica cathepsin L suppresses sheep lymphocyte proliferation in vitro and modulates surface CD4 expression on human and ovine T cells.Exercise and T-lymphocyte function: a comparison of proliferation in PBMC and NK cell-depleted PBMC culture.Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy.The extracellular domain of CD4 receptor possesses a protein kinase activity.From pathology to physiology of the human T-lymphocyte receptor.
P2860
Q24312993-5CAB4BC0-86EA-47CC-BCFC-AFCD0797C76DQ24558732-198916E2-5DDD-489E-9593-F2F790DB4889Q28281212-B0C1F8AE-F09E-48F1-814B-BB12AE32DEB8Q33658291-559F2B3A-E58B-46B9-830A-3BFB7EFF2D5AQ34128771-1379DBAF-D39A-46E8-A861-A21238DE8C0BQ35108593-DA0AE9D4-FD6D-428C-9F1D-7DADF0DC1FB2Q35862050-05EAF42D-624E-42F4-ACC7-F85EF7ADBB2FQ36191499-EE5CE2FC-EC7D-43EE-9D56-AD88E351189BQ36231558-5A1DE0A9-D015-4931-804A-5E7525DB0148Q36337258-40A2B75F-0342-4495-AE6C-4B7F3D76C0A5Q36363974-0B3548B3-1E2B-4DFF-9C7C-214086B8E76CQ36747167-A4359A7D-6BAF-47EC-BDDD-33F67166F302Q36852692-9F96CFE0-5460-45EF-AB69-108A1929170AQ37223643-0B1B6AAF-599E-4397-8321-05B961F4C377Q37296608-CB386255-6AC5-4830-852C-785BA01583E1Q37538510-7DB0F0BC-1975-47A0-B2FF-0C8828AD8BB3Q37568420-B1BC19B0-4BF8-439B-B25B-4F73EE975D13Q37999087-12413F32-EF1D-4F95-9ECC-9EF180C2523DQ40872594-849D2789-866A-49F5-BBE5-0CAB7F4668E4Q41457909-915A5EC2-ABBB-4360-B75A-09D1E98B18FCQ41625906-61D37830-DE8B-496F-8691-4FDF41E1A31CQ41719612-187D7608-AF16-4B90-98DD-455F50F1D97FQ41821340-F8FD5696-F8C4-4EBE-B8A8-724D2A1B7090Q42551150-1BD15CC1-F891-4BF7-A6BA-E2A4431B29F5Q43511256-C12D6922-EBC5-428F-9012-A3CA668A6D2DQ43533434-F2485100-912C-469B-8556-D0D46CDD3447Q43902970-3F5D18ED-44AF-4CFF-8E1A-CFD8DBEF6864Q43996701-5933A656-77CB-46FA-98DF-DCFB933F897CQ45874782-2A91BF9A-29CF-4203-91CE-54C20B52F657Q47764059-A5652F1F-63B5-4008-A9C0-625E4638298EQ51149327-B0D4585C-371F-466B-91EE-C7426D3B7DC0
P2860
The role of CD4 in T-cell activation: accessory molecule or co-receptor?
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
The role of CD4 in T-cell activation: accessory molecule or co-receptor?
@en
type
label
The role of CD4 in T-cell activation: accessory molecule or co-receptor?
@en
prefLabel
The role of CD4 in T-cell activation: accessory molecule or co-receptor?
@en
P1433
P1476
The role of CD4 in T-cell activation: accessory molecule or co-receptor?
@en
P2093
Janeway CA Jr
P304
P356
10.1016/0167-5699(89)90260-0
P577
1989-07-01T00:00:00Z